A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Benzonatate
Midostaurin
The metabolism of Sunitinib can be increased when combined with Midostaurin.
Benzonatate
St. John's Wort
The metabolism of St. John's Wort can be increased when combined with Sunitinib.
Benzonatate
Relugolix
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Relugolix.
Benzonatate
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Acetyldigoxin.
Benzonatate
Mirabegron
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Mirabegron.
Benzonatate
Indacaterol
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Indacaterol.
Benzonatate
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Sunitinib.
Benzonatate
Niguldipine
The risk or severity of QTc prolongation can be increased when Niguldipine is combined with Sunitinib.
Benzonatate
Lidoflazine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lidoflazine.
Benzonatate
Bencyclane
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Bencyclane.
Benzonatate
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Tetrahydropalmatine.
Benzonatate
Rupatadine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Rupatadine.
Benzonatate
Lacidipine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Lacidipine.
Benzonatate
Aranidipine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Aranidipine.
Benzonatate
Pinaverium
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Pinaverium.
Benzonatate
Trimebutine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Trimebutine.
Benzonatate
Levocetirizine
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Levocetirizine.
Benzonatate
Solifenacin
The risk or severity of QTc prolongation can be increased when Sunitinib is combined with Solifenacin.
Benzonatate
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Sunitinib.
Benzonatate
Perhexiline
The risk or severity of QTc prolongation can be increased when Perhexiline is combined with Sunitinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3